Recombinant Ag85B vaccine by taking advantage of characteristics of human parainfluenza type 2 virus vector showed Mycobacteria-specific immune responses by intranasal immunization. [electronic resource]
- Vaccine Mar 2014
- 1727-35 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't